COMPANY INFO
Matter Bio is a biotechnology company founded in 2022 and headquartered in New York, NY. It was co-founded by Christopher Bradley and George Church, PhD, and employs around 6-8 people. The company focuses on longevity through DNA information preservation by developing biotechnology research services aimed at countering genome information loss to increase patient longevity through mutation reversal.
Matter Bio is a biotechnology company founded in 2022, headquartered in Brooklyn, New York. The company develops innovative research services aimed at countering genome information loss and increasing patient longevity through DNA information preservation and mutation reversal.
The Matter Bio leadership team brings together extensive expertise across biotechnology innovation, commercial strategy, technology development, and financial management. With accomplished founders, scientists, technologists, and seasoned executives, the Matter Bio management team leverages both industry-leading research credentials and operational know-how to drive the company’s growth and scientific breakthroughs in longevity and DNA preservation.
As CEO and Co-Founder of Matter Bio, Christopher Bradley leads the organization’s mission to extend human longevity through DNA information preservation technologies. Bradley is instrumental in shaping the company vision, driving strategic partnerships, and overseeing both scientific and commercial initiatives that position Matter Bio at the forefront of biotechnology innovation.
Bradley holds a Master’s Degree from NYU Tandon School of Engineering and brings a track record of biotechnology entrepreneurship and academic contributions. He previously served as CEO and Founder of Loki Therapeutics, is an adjunct professor at New York University, and has held advisory roles in several biotech startups—demonstrating expertise that spans from technology innovation to business leadership.
Jim Keefer brings over twelve years of operational leadership to Matter Bio as COO. Keefer oversees company operations, process optimization, and strategic execution, ensuring the organization runs efficiently and scales its research initiatives effectively to support rapid growth.
Jim Keefer studied Biochemistry and Physiology at University of California, Davis, and has developed a wealth of experience in operational and leadership roles across the biotech and life sciences sectors, making him a vital part of the Matter Bio management team.
Mike Mattern serves as Vice President and COO, supporting operational leadership and strategic planning to drive Matter Bio's growth trajectory. He excels in operational excellence, team management, and business development, drawing on over two decades of success in the biotech industry.
Mattern holds a PhD in Biochemistry and Molecular Biology from Princeton University. He previously held senior investigator roles at GlaxoSmithKline, giving him deep industry insight and technical expertise.
Matthew Dean Brovold, PhD is the company’s Chief Science Officer and Co-Founder, driving the scientific research and innovation engine at Matter Bio. He leads projects developing printable universal bioinks for 3D cell culture and bioengineered organs, ensuring that the company continues to break new ground in DNA mutation reversal and organoid technology.
Dr. Brovold earned his PhD from Wake Forest University and holds a BS in Genetics, Cellular and Developmental Biology from Arizona State University. Before joining Matter Bio, he managed research teams at ReMDO and conducted postdoctoral work at the Wake Forest Institute for Regenerative Medicine. He has published extensively in the fields of biotechnology and bioengineering.
Anubhav Dubey serves as Chief Technology Officer, leading the development of advanced diagnostic methods and at-home testing technologies. Dubey’s expertise in technological innovation has helped Matter Bio advance early detection platforms for infectious diseases, cancer, and general health.
Dubey is a Georgia Institute of Technology graduate and has previously held CTO roles at Stealth Mode Biotech and Matter Diagnostics, positioning him as a thought leader in biotechnology technology and early disease detection.
Ning Yang, as Chief Financial Officer, manages the financial operations, strategic planning, and investor relations for Matter Bio. Her financial leadership underpins the company’s continued growth and ability to secure investment for breakthrough research initiatives.
Yang holds an MBA from NYU Stern School of Business, a BS in Accounting and Finance from Lehigh University, and is a Certified Public Accountant. She brings eight years of financial leadership—having previously worked as a Senior Tax Consultant at Deloitte.
Alan Thomas, MBA CPA serves as Portfolio CFO, providing strategic financial advisory services and supporting financial planning, analysis, and risk management. His insights into biotech financial structures optimize fiscal performance and mitigate risks for Matter Bio.
Thomas earned his MBA from the University of Victoria and is a Chartered Professional Accountant. With CFO experience at Geno10X Biosciences and Maximus Canada, he brings extensive finance and accounting expertise to the company’s leadership.
Chris Muller is a Founding Member and Chief Commercial Officer, leading commercial strategy, marketing, and business growth initiatives. Muller’s expertise supports Matter Bio’s positioning and partnership development in the biotechnology sector.
He holds a BS and MBA from Whittier College and Pepperdine University, respectively, and previously served as VP and CCO at Allergan, AMO, Abbott, and QLT, gaining significant expertise in biotech marketing and management.
The Matter Bio leadership team combines the talents of visionary founders, expert scientists, dynamic technologists, and seasoned executives. The management team draws on extensive experience across biotechnology innovation, commercialization, operational management, and financial strategy—structuring a diverse executive group that propels Matter Bio’s mission in DNA preservation and longevity. This collaborative leadership culture supports sustained innovation while maintaining agility in a fast-evolving biotech landscape.
Websets is a powerful natural language search and data enrichment tool that helps you research executive teams for any company. Whether you're analyzing the Matter Bio leadership team or exploring management structures at other organizations, Websets provides comprehensive insights into executive backgrounds, roles, and team dynamics.
With Websets, you can access detailed executive team profiles, management structures, and leadership insights through intuitive natural language queries. Sign up now to enhance your executive team research capabilities.